Skip to main content
. 2014 Aug 20;2014:683160. doi: 10.1155/2014/683160

Table 4.

Mutations in CD40L gene and CD40L expression in patients with XHIGM.

Patients (n = 20) Genomic DNA mutation (NC_000023.10) cDNA mutation (NM_000074.2) Predicted effect on protein (NP_000065.1) Affected domain Exon/intron CD40L expression References
P1 g.175delC c.175delC p.Gln35ArgfsX36 TM Exon 1 NA
P2 g.186delG c.186delG p.Ser39GlnfsX48 TM Exon 1 0.09%
P3 g.186delG c.186delG p.Ser39GlnfsX48 TM Exon 1 0.31%
P4 g.6196g>a (IVS2-1g>a) Skipping exon3 Skipping exon3 Intron 2 NA
P5 g.8181_8182insGT c.420_421insGT p.Asp117ValfsX128 ECU Exon 4 0.02%
P6∗ g.10952G>C c.499G>C p.Gly167Arg TNFH Exon 5 0.27% [39]
P7∗ g.11160C>A c.707C>A p.Ser236X TNFH Exon 5 0.75% [36]
P8 g.11069_11072delCTCA c.616_619delCTCA p.Leu206GlufsX240 TNFH Exon 5 0.80%
P9∗ g.12090C>A c.654C>A p.C218X TNFH Exon 5 NA [18, 19, 43]
P10∗ g.10861a>g (IVS4-2a>g) c.482delTGTTACAG Exon5 absent TNFH Intron 4 0.31% [37]
P11 g.100C>T c.100C>T p.Pro10Ser IC Exon 1 4.55%
P12∗ g.2091_2094delTAGA c.158_161delTAGA p.Ile53LysfsX65 ECU Exon 2 0.01% [18, 19, 44, 45]
P13 g.11220T>C c.767T>C p.Phe256Ser TNFH Exon 5 0.53%
P14 g.11067T>C c.686T>C p.Leu205Ser TNFH Exon 5 1.78%
P15 g.173_189delcccagatgattgggtca c.173_189delcccagatgattgggtca p.Thr34CysfsX42 TM Exon 1 0.42%
P16∗ g.2091_2094delTAGA c.158_161delTAGA p.Ile53fsLysX65 ECU Exon 2 NA [18, 19, 44, 45]
P17 g.11075G>C c.694G>C p.Ala208Pro TNFH Exon 5 NA
P18 g.10986delG c.605delG p.Cys178PhefsX190 TNFH Exon 5 NA
P19 g.10882_10883insA c.501_502insA p.Gly144ArgfsX158 TNFH Exon 5 NA
P20∗ g.10871T>C c.490T>C p.Trp140Arg TNFH Exon 5 NA [19, 38]

Note: ∗mutation that has been reported. IC: intracytoplasmic domain; TM: transmembrane region; ECU: extracellular unique domain; TNFH: tumor necrosis factor homology domain; NA: not available.